文献速递结核与非结核分枝杆菌

新型舌拭子即时检测诊断肺结核的多中心前瞻性研究

Diagnostic accuracy of a novel point-of-care tongue swab assay for pulmonary tuberculosis: a multicentre prospective study.
PubMed 文献 · Clin Microbiol Infect · 2025-11-15

该多中心前瞻性研究纳入594例疑似症状性肺结核患者,评估MiniDock MTB检测系统在舌拭子和痰标本上的诊断性能。痰MiniDock与Xpert相比敏感度98.2%、特异度90.4%;舌拭子MiniDock敏感度80.0%、特异度95.4%。舌拭子敏感度随菌量降低而下降,但无创高接受度使其成为无法咳痰者的补充工具。

要点

  • 痰MiniDock对肺结核诊断敏感度98.2%、特异度90.4%(对照Xpert)。
  • 舌拭子MiniDock敏感度80.0%、特异度95.4%,适合无法咳痰者补充。
  • 舌拭子敏感度随菌量下降,极低菌量样本仅47.8%。

核心结论

  • MiniDock使用舌拭子和痰标本为结核病提供快速、可靠、无创的即时检测诊断选择。
  • 舌拭子MiniDock敏感度较低,但高接受度使其成为无法咳痰者的有价值补充工具。

研究设计与样本

  • 前瞻性多中心研究,纳入广东省七家结核病医院594例疑似症状性肺结核参与者。
  • 舌拭子和痰标本采用Pluslife的MiniDock系统检测;痰标本同时行Xpert MTB/RIF、涂片镜检和MGIT培养。
  • 诊断性能与MGIT培养、痰Xpert及复合微生物参考标准(MRS)比较。

主要发现

  • 痰MiniDock与痰Xpert相比敏感度98.2%(95% CI 95.7-99.2%)、特异度90.4%(95% CI 86.7-93.2%)。
  • 痰MiniDock与MRS相比敏感度94.2%(95% CI 90.9-96.6%)、特异度93.7%(95% CI 90.3-96.1%)。
  • 舌拭子MiniDock与痰Xpert相比敏感度80.0%(95% CI 74.8-84.3%)、特异度95.4%(95% CI 92.5-97.2%)。
  • 舌拭子MiniDock与MRS相比敏感度74.5%(95% CI 69.1-79.4%)、特异度96.0%(95% CI 93.1-97.9%)。
  • 舌拭子MiniDock敏感度随菌量变化:高菌量98.2%(95% CI 90.2-99.7%),极低菌量47.8%(95% CI 29.2-67.0%);痰对应为100%(95% CI 93.4-100.0%)和87.0%(95% CI 67.9-95.5%)。

临床怎么用

  • 痰MiniDock可作为肺结核快速分子诊断工具,性能与Xpert接近。
  • 舌拭子MiniDock适用于无法咳痰的疑似肺结核患者,作为补充检测。
  • 对极低菌量样本,舌拭子MiniDock敏感度有限,阴性结果需结合临床判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Tuberculosis (TB) remains a leading cause of infectious disease deaths, with underdiagnosis driving ongoing transmission. We evaluated the diagnostic performance of the MiniDock MTB Test (MiniDock), an innovative point-of-care testing molecular system, using tongue swab and sputum specimens. METHODS: This prospective multicentre study enrolled 594 participants with suspected symptomatic pulmonary TB across seven TB hospitals in Guangdong Province. Tongue swabs and sputum samples were tested using MiniDock system of Pluslife. Sputum specimens were evaluated with Xpert MTB/RIF (Xpert), smear microscopy, and mycobacteria growth indicator tube culture. The diagnostic performance of MiniDock was compared with that of mycobacteria growth indicator tube culture and sputum Xpert findings. Diagnostic performance was compared against a composite microbiological reference standard (MRS). RESULTS: The sputum MiniDock demonstrated sensitivity and specificity of 98.2% (95% CI, 95.7-99.2%) and 90.4% (95% CI, 86.7-93.2%), compared with sputum Xpert, and 94.2% (95% CI, 90.9-96.6%) and 93.7% (95% CI, 90.3-96.1%) compared with the MRS. The MiniDock test with tongue swabs had a sensitivity of 80.0% (95% CI, 74.8-84.3%) and a specificity of 95.4% (95% CI, 92.5-97.2%) compared with sputum Xpert, and 74.5% (95% CI, 69.1-79.4%) and 96.0% (95% CI, 93.1-97.9%) compared with the MRS. The sensitivity of tongue swab MiniDock varied by bacterial load, ranging from 98.2% (95% CI, 90.2-99.7%) in high-load samples to 47.8% (95% CI, 29.2-67.0%) in very-low-load samples; for sputum samples, the corresponding sensitivities were 100% (95% CI, 93.4-100.0%) and 87.0% (95% CI, 67.9-95.5%), respectively. CONCLUSIONS: The MiniDock test using tongue swabs and sputum provides a rapid, reliable, and noninvasive point-of-care testing diagnostic option for TB. Although the tongue swab MiniDock has lower sensitivity, its high acceptability makes it a valuable supplementary tool for individuals unable to produce sputum.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Wu Z, Yan L, Lai X, et al. Diagnostic accuracy of a novel point-of-care tongue swab assay for pulmonary tuberculosis: a multicentre prospective study. Clin Microbiol Infect. 2025. PMID: 41248712. doi:10.1016/j.cmi.2025.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。